RIGL - RIGEL PHARMACEUTICALS INC
28.87
-0.650 -2.251%
Share volume: 354,349
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$29.52
-0.65
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-06-2024 | 11-07-2024 | 03-04-2025 | 05-06-2025 | 08-05-2025 | 11-04-2025 | 03-03-2026 | |
| Cash flow financing | -2.512 M | -752.000 K | -9.842 M | 1.465 M | 484.000 K | 418.000 K | 4.271 M | -4.572 M | |
| Other financing cash flows | 0.000 | -1.004 M | -10.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -5.013 M | 10.479 M | 15.639 M | 5.054 M | -10.961 M | 7.679 M | -4.873 M | -7.954 M | |
| Net income | -8.247 M | -1.030 M | 12.421 M | 14.341 M | 11.446 M | 59.613 M | 27.900 M | 268.065 M | |
| Depreciation | 400.000 K | 613.000 K | 611.000 K | 604.000 K | 604.000 K | 607.000 K | 603.000 K | 601.000 K | |
| Changes in inventories | 6.579 M | 0.000 | 0.000 | 0.000 | -1.413 M | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 27.512 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 313.000 K | 10.929 M | 3.802 M | -10.914 M | -10.552 M | -23.276 M | -33.175 M | -25.362 M | |
| Net Borrowings | 1.295 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -138.000 K | 0.000 | -26.000 K | -46.000 K | 0.000 | 0.000 | 0.000 | -12.000 K | |
| Cash Change | 49.550 M | 10.479 M | 15.639 M | 5.054 M | -10.961 M | 7.679 M | -4.873 M | -7.954 M |